Charles River Laboratories Total Current Assets 2010-2024 | CRL

Charles River Laboratories total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Charles River Laboratories total current assets for the quarter ending September 30, 2024 were $1.495B, a 3.49% increase year-over-year.
  • Charles River Laboratories total current assets for 2023 were $1.609B, a 11.79% increase from 2022.
  • Charles River Laboratories total current assets for 2022 were $1.439B, a 12.95% increase from 2021.
  • Charles River Laboratories total current assets for 2021 were $1.274B, a 6.07% increase from 2020.
Charles River Laboratories Annual Total Current Assets
(Millions of US $)
2023 $1,609
2022 $1,439
2021 $1,274
2020 $1,201
2019 $1,021
2018 $898
2017 $827
2016 $657
2015 $559
2014 $579
2013 $553
2012 $485
2011 $426
2010 $553
2009 $596
Charles River Laboratories Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $1,495
2024-06-30 $1,499
2024-03-31 $1,668
2023-12-31 $1,609
2023-09-30 $1,444
2023-06-30 $1,505
2023-03-31 $1,448
2022-12-31 $1,439
2022-09-30 $1,415
2022-06-30 $1,393
2022-03-31 $1,333
2021-12-31 $1,274
2021-09-30 $1,379
2021-06-30 $1,268
2021-03-31 $1,423
2020-12-31 $1,201
2020-09-30 $1,140
2020-06-30 $1,235
2020-03-31 $1,208
2019-12-31 $1,021
2019-09-30 $972
2019-06-30 $1,010
2019-03-31 $866
2018-12-31 $898
2018-09-30 $838
2018-06-30 $890
2018-03-31 $843
2017-12-31 $827
2017-09-30 $782
2017-06-30 $738
2017-03-31 $700
2016-12-31 $657
2016-09-30 $655
2016-06-30 $702
2016-03-31 $637
2015-12-31 $559
2015-09-30 $579
2015-06-30 $630
2015-03-31 $614
2014-12-31 $579
2014-09-30 $606
2014-06-30 $593
2014-03-31 $591
2013-12-31 $553
2013-09-30 $548
2013-06-30 $520
2013-03-31 $493
2012-12-31 $485
2012-09-30 $458
2012-06-30 $452
2012-03-31 $437
2011-12-31 $426
2011-09-30 $456
2011-06-30 $548
2011-03-31 $561
2010-12-31 $553
2010-09-30 $527
2010-06-30 $608
2010-03-31 $614
2009-12-31 $596
2009-09-30 $566
2009-06-30 $570
2009-03-31 $582
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00